Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
408 adverse event reports (-7% vs 2024)
In 2025, 408 adverse event reports were filed for DTaP + Hepatitis B + IPV (Pediarix) in VAERS. This represents 2.7% of all 15,041 reports for this vaccine.
Of these reports, 11 mentioned death, 29 involved hospitalization, 63 required ER visits, and 11 reported disability.
Compared to the average of 606 reports per year for this vaccine, 2025 was below average (-33%).
In 2025, reporting for DTaP + Hepatitis B + IPV (Pediarix) was within typical ranges. As always, VAERS data reflects reports filed, not confirmed adverse events. Trends should be interpreted alongside vaccination volume and population health data.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.